Literature DB >> 19649144

Apolipoprotein E and cholesterol in aging and disease in the brain.

Elena Posse de Chaves1, Vasanthy Narayanaswami.   

Abstract

Cholesterol can be detrimental or vital, and must be present in the right place at the right time and in the right amount. This is well known in the heart and the vascular system. However, in the CNS cholesterol is still an enigma, although several of its fundamental functions in the brain have been identified. Brain cholesterol has attracted additional attention owing to its close connection to ApoE, a key polymorphic transporter of extracellular cholesterol in humans. Indeed, both cholesterol and ApoE are so critical to fundamental activities of the brain, that the brain regulates their synthesis autonomously. Yet, similar control mechanisms of ApoE and cholesterol homeostasis may exist on either sides of the blood-brain barrier. One indication is that the APOE ε4 allele is associated with hypercholesterolemia and a proatherogenic profile on the vascular side and with increased risk of Alzheimer's disease on the CNS side. In this review, we draw attention to the association between cholesterol and ApoE in the aging and diseased brain, and to the behavior of the ApoE4 protein at the molecular level. The attempt to correlate in vivo and in vitro observations is challenging but crucial for developing future strategies to address ApoE-related aberrations in cholesterol metabolism selectively in the brain.

Entities:  

Year:  2008        PMID: 19649144      PMCID: PMC2600507          DOI: 10.2217/17460875.3.5.505

Source DB:  PubMed          Journal:  Future Lipidol        ISSN: 1746-0875


  320 in total

1.  Molecular determinants of the interaction between the C-terminal domain of Alzheimer's beta-amyloid peptide and apolipoprotein E alpha-helices.

Authors:  L Lins; A Thomas-Soumarmon; T Pillot; J Vandekerchkhove; M Rosseneu; R Brasseur
Journal:  J Neurochem       Date:  1999-08       Impact factor: 5.372

Review 2.  Alzheimer's disease pathogenesis and therapeutic interventions.

Authors:  M S Parihar; Taruna Hemnani
Journal:  J Clin Neurosci       Date:  2004-06       Impact factor: 1.961

3.  Modulation of the lipid binding properties of the N-terminal domain of human apolipoprotein E3.

Authors:  P M Weers; V Narayanaswami; R O Ryan
Journal:  Eur J Biochem       Date:  2001-07

4.  Age-related congophilic inclusions in the brains of apolipoprotein E-deficient mice.

Authors:  T A Robertson; N S Dutton; R N Martins; A D Roses; B A Kakulas; J M Papadimitriou
Journal:  Neuroscience       Date:  1998-01       Impact factor: 3.590

5.  Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: neuropathologic evidence for a mechanism of increased beta-amyloidogenesis.

Authors:  A M Cataldo; J L Barnett; C Pieroni; R A Nixon
Journal:  J Neurosci       Date:  1997-08-15       Impact factor: 6.167

6.  Selective alterations in the cellular distribution of apolipoprotein E immunoreactivity following transient cerebral ischaemia in the rat.

Authors:  K Horsburgh; J A Nicoll
Journal:  Neuropathol Appl Neurobiol       Date:  1996-08       Impact factor: 8.090

7.  An apolipoprotein preferentially enriched in cholesteryl ester-rich very low density lipoproteins.

Authors:  B Shore; V Shore
Journal:  Biochem Biophys Res Commun       Date:  1974-05-07       Impact factor: 3.575

8.  Detection of apolipoprotein E/dimeric soluble amyloid beta complexes in Alzheimer's disease brain supernatants.

Authors:  B Permanne; C Perez; C Soto; B Frangione; T Wisniewski
Journal:  Biochem Biophys Res Commun       Date:  1997-11-26       Impact factor: 3.575

9.  Apolipoprotein E: binding to soluble Alzheimer's beta-amyloid.

Authors:  T Wisniewski; A Golabek; E Matsubara; J Ghiso; B Frangione
Journal:  Biochem Biophys Res Commun       Date:  1993-04-30       Impact factor: 3.575

10.  Role of phosphatidylinositol(4,5)bisphosphate organization in membrane transport by the Unc104 kinesin motor.

Authors:  Dieter R Klopfenstein; Michio Tomishige; Nico Stuurman; Ronald D Vale
Journal:  Cell       Date:  2002-05-03       Impact factor: 41.582

View more
  53 in total

1.  Conformational analysis of apolipoprotein E3/E4 heteromerization.

Authors:  Kai-Han Tu; Devan Abhari; Vasanthy Narayanaswami
Journal:  FEBS J       Date:  2019-03-13       Impact factor: 5.542

Review 2.  The Complex Role of Apolipoprotein E in Alzheimer's Disease: an Overview and Update.

Authors:  Laura Mahoney-Sanchez; Abdel Ali Belaidi; Ashley I Bush; Scott Ayton
Journal:  J Mol Neurosci       Date:  2016-09-19       Impact factor: 3.444

3.  Altered Cholesterol Intracellular Trafficking and the Development of Pathological Hallmarks of Sporadic AD.

Authors:  Xuesong Chen; Liang Hui; Mahmoud L Soliman; Jonathan D Geiger
Journal:  J Parkinsons Dis Alzheimers Dis       Date:  2014

4.  Role of endolysosomes and cholesterol in the pathogenesis of Alzheimer's disease: Insights into why statins might not provide clinical benefit.

Authors:  Xuesong Chen; Liang Hui; Jonathan D Geiger
Journal:  Austin J Pharmacol Ther       Date:  2014-08-26

5.  Donepezil effects on cholesterol and oxysterol plasma levels of Alzheimer's disease patients.

Authors:  Alana C Costa; Helena P G Joaquim; Valéria S Nunes; Daniel S Kerr; Guilherme S Ferreira; Orestes V Forlenza; Wagner F Gattaz; Leda Leme Talib
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-08-31       Impact factor: 5.270

6.  Full-length apolipoprotein E protects against the neurotoxicity of an apoE-related peptide.

Authors:  K A Crutcher; H N Lilley; S R Anthony; W Zhou; V Narayanaswami
Journal:  Brain Res       Date:  2009-10-21       Impact factor: 3.252

7.  Diet and age interactions with regards to cholesterol regulation and brain pathogenesis.

Authors:  Romina M Uranga; Jeffrey N Keller
Journal:  Curr Gerontol Geriatr Res       Date:  2010-04-11

Review 8.  Omega-3 fatty acids: potential role in the management of early Alzheimer's disease.

Authors:  Gregory A Jicha; William R Markesbery
Journal:  Clin Interv Aging       Date:  2010-04-07       Impact factor: 4.458

9.  Genetic markers of cholesterol transport and gray matter diffusion: a preliminary study of the CETP I405V polymorphism.

Authors:  Lauren E Salminen; Peter R Schofield; Kerrie D Pierce; Xi Luo; Yi Zhao; David H Laidlaw; Ryan P Cabeen; Thomas E Conturo; Elizabeth M Lane; Jodi M Heaps; Jacob D Bolzenius; Laurie M Baker; Sarah A Cooley; Staci Scott; Lee M Cagle; Robert H Paul
Journal:  J Neural Transm (Vienna)       Date:  2015-08-08       Impact factor: 3.575

Review 10.  Apolipoprotein E genotype and hepatitis C, HIV and herpes simplex disease risk: a literature review.

Authors:  Inga Kuhlmann; Anne Marie Minihane; Patricia Huebbe; Almut Nebel; Gerald Rimbach
Journal:  Lipids Health Dis       Date:  2010-01-28       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.